Alert detail

LCD L37725: MolDX: Melanoma Risk Stratification Molecular Testing — Palmetto GBA

Policy ID: LCD-L37725Specialty: DermatologyAdded: 6/5/2026Effective: June 26, 2025lcd
High

What changed

Prepare for changes in melanoma risk testing reimbursements.

Who’s affected: Dermatology billing teams · Effective: June 26, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 9 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.